Weekly Wrap-Up with Dan Bishop
Story Date: 1/31/2022

  Source: US Rep. Dan Bishop (NC-9th)
 


Dear Friend,

 

Today, I sent a letter with Rep. Jim Jordan (OH-04) and 14 House Judiciary Republicans to Attorney General Merrick Garland, demanding that the Department of Justice (DOJ) confront the U.S. Food and Drug Administration’s (FDA) race-based guidance for allocating life-saving monoclonal antibody treatments.

 

TWEET: Judiciary Republicans are demanding AG Garland take action

 

You may remember that last week, I authored a letter to FDA Acting Commissioner Dr. Janet Woodcock, along with 30 of my House colleagues, concerning this very same guidance from Biden’s FDA. In sum, the Biden Administration issued guidance to states outlining how health care providers should distribute monoclonal antibody treatments, not based on medical need, but on the basis of race.

 

There’s no other way to put it, the Biden Administration’s guidance divides Americans by race in violation of the 14th Amendment of the Constitution. They want to prioritize race over high-risk medical conditions when allocating life-saving treatments.

 

An even bigger problem is that based on this guidance, several states such as New York, Minnesota, and Utah, have already implemented this discriminatory policy.

 

“These shocking displays of racial discrimination run counter to the principles we hold dear as Americans,” my colleagues and I wrote to AG Garland. “The Fourteenth Amendment to the Constitution provides that no State shall 'deny to any person within its jurisdiction the equal protection of the laws.’ Unfortunately, the inhabitants of these states are receiving different treatment from their own state governments based in no small part on their racial background.”

 

“That is simply un-American. Racism is an evil that our country has fought against for generations, and we must stand up for the rights of all Americans to receive equal protection under the law.”

 

TWEET: There’s nothing more un-American than Biden’s FDA guidance

 

No one should be denied life-saving treatments due to their race. It really is that simple. Worse yet, states are already rationing monoclonal antibody treatments due to the Biden Administration's horrific decision to federalize the entire supply. Simply put, this administration’s radical politics are putting Americans’ lives at risk.

 

The DOJ must step in to protect Americans from such unlawful discriminatory practices. I am demanding Attorney General Garland to take action on this issue.

 

MORE: Bishop fires off letter over national monoclonal antibody supply

 

 

 

OSHA Vaccine Mandate Withdrawn

 

If you missed it earlier this week, some great news was announced regarding President Biden’s unconstitutional vaccine mandate. The Occupational Safety and Health Administration (OSHA) broke the news that they have withdrawn their vaccine-or-test mandate for workers at large businesses after the Supreme Court ruled to block the mandate just a few weeks ago.

 

TWEET: Biden’s vaccine mandate should’ve never seen the light of day

 

This is a win for freedom.

 

President Biden’s mandate cost people their livelihoods and should have never even been introduced in the first place. The Supreme Court made clear that no Administration can write their own laws, but that is exactly what the Biden Administration tried to do. Now, they have finally backed down on this unconstitutional mandate. This is good news for American businesses and workers.

 

TWEET: We should not be funding Biden’s vaccine mandates

 

While this is welcomed news, my colleagues and I are committed to ensuring that Congress defends Americans' liberty. We must stand together to stop the federal government from funding these unconstitutional vaccine mandates any longer. 

 

MORE: The Biden Admin must stop tracking religious exemptions for vaccine mandates

 

Sincerely,

 

Dan Bishop
Member of Congress

























   Copyright © 2007 North Carolina Agribusiness Council, Inc. All Rights Reserved.
   All use of this Website is subject to our
Terms of Use Agreement and our Privacy Policy.